Skip to main content
. 2020 Jun 3;295(29):9998–10007. doi: 10.1074/jbc.RA120.014064

Figure 3.

Figure 3.

The D231A/H314 mutation enhances spectrally detectable binding of substrate to human CYP51. A, absolute absorbance spectra before (blue) and after (black) titration with lanosterol. B, high-spin-form content in the protein samples (n = 2 ± S.D.).